180 related articles for article (PubMed ID: 29610853)
1. A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing.
Prasanna G; Ferrara L; Adams C; Ehara T; Li B; Yang L; Xiang C; Ng CTH; Kim S; Towler C; Topley T; McAllister C; Ghosh M; Newton R; Stacy R; Rice DS; Mogi M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1704-1716. PubMed ID: 29610853
[TBL] [Abstract][Full Text] [Related]
2. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
[TBL] [Abstract][Full Text] [Related]
3. Guanylate cyclase activators, cell volume changes and IOP reduction.
Ellis DZ
Cell Physiol Biochem; 2011; 28(6):1145-54. PubMed ID: 22179003
[TBL] [Abstract][Full Text] [Related]
4. Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
Krauss AH; Impagnatiello F; Toris CB; Gale DC; Prasanna G; Borghi V; Chiroli V; Chong WK; Carreiro ST; Ongini E
Exp Eye Res; 2011 Sep; 93(3):250-5. PubMed ID: 21396362
[TBL] [Abstract][Full Text] [Related]
5. A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
Borghi V; Bastia E; Guzzetta M; Chiroli V; Toris CB; Batugo MR; Carreiro ST; Chong WK; Gale DC; Kucera DJ; Jia L; Prasanna G; Ongini E; Krauss AH; Impagnatiello F
J Ocul Pharmacol Ther; 2010 Apr; 26(2):125-32. PubMed ID: 20415621
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
7. Effects of topical ethacrynic acid ointment vs timolol on intraocular pressure in glaucomatous monkey eyes.
Wang RF; Podos SM; Serle JB; Lee PY; Neufeld AH; Deschenes R
Arch Ophthalmol; 1994 Mar; 112(3):390-4. PubMed ID: 8129666
[TBL] [Abstract][Full Text] [Related]
8. Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action.
Sharif NA
Curr Drug Targets; 2010 Aug; 11(8):978-93. PubMed ID: 20426763
[TBL] [Abstract][Full Text] [Related]
9. AL-34662: a potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist.
Sharif NA; McLaughlin MA; Kelly CR
J Ocul Pharmacol Ther; 2007 Feb; 23(1):1-13. PubMed ID: 17341144
[TBL] [Abstract][Full Text] [Related]
10. Effect of SPP 301, an endothelin antagonist, on intraocular pressure in glaucomatous monkey eyes.
Wang RF; Podos SM; Serle JB; Baltatu OC
Curr Eye Res; 2011 Jan; 36(1):41-6. PubMed ID: 21174596
[TBL] [Abstract][Full Text] [Related]
11. Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272.
Hobbs AJ; Moncada S
Vascul Pharmacol; 2003 Oct; 40(3):149-54. PubMed ID: 13678646
[TBL] [Abstract][Full Text] [Related]
12. Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.
Sharif NA; McLaughlin MA; Kelly CR; Katoli P; Drace C; Husain S; Crosson C; Toris C; Zhan GL; Camras C
Exp Eye Res; 2009 Mar; 88(3):386-97. PubMed ID: 18992242
[TBL] [Abstract][Full Text] [Related]
13. Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
Gagliuso DJ; Wang RF; Mittag TW; Podos SM
Arch Ophthalmol; 2004 Sep; 122(9):1342-7. PubMed ID: 15364714
[TBL] [Abstract][Full Text] [Related]
14. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Easthope SE; Perry CM
Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
[TBL] [Abstract][Full Text] [Related]
15. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
Wang RF; Gagliuso DJ; Mittag TW; Podos SM
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
[TBL] [Abstract][Full Text] [Related]
16. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
[TBL] [Abstract][Full Text] [Related]
17. Effect of acute increases of intraocular pressure on corneal pachymetry in eyes treated with travoprost: an animal study.
Bolívar G; Teus M; Arranz-Marquez E
Curr Eye Res; 2011 Nov; 36(11):1014-9. PubMed ID: 21942300
[TBL] [Abstract][Full Text] [Related]
18. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist.
Hellberg MR; Sallee VL; McLaughlin MA; Sharif NA; Desantis L; Dean TR; Zinke PW
J Ocul Pharmacol Ther; 2001 Oct; 17(5):421-32. PubMed ID: 11765147
[TBL] [Abstract][Full Text] [Related]
19. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.
Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891
[TBL] [Abstract][Full Text] [Related]
20. Effects of topical H-7 on outflow facility, intraocular pressure, and corneal thickness in monkeys.
Tian B; Wang RF; Podos SM; Kaufman PL
Arch Ophthalmol; 2004 Aug; 122(8):1171-7. PubMed ID: 15302658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
